Omeros Corporation

(NASDAQ:OMER)

Latest On Omeros Corporation (OMER):

Date/Time Type Description Signal Details
2023-05-17 06:30 ESTNewsOmeros: Q1 Earning Overview, Best Contrarian Biotech Play Of 2023N/A
2023-05-10 05:46 ESTNewsOmeros Corporation (OMER) Q1 2023 Earnings Call TranscriptN/A
2023-05-09 16:40 ESTNewsOmeros GAAP EPS of -$0.63 misses by $0.09N/A
2023-05-09 02:50 ESTNewsOmeros Q1 2023 Earnings PreviewN/A
2023-04-25 20:18 ESTNewsOmeros reports positive data for rare blood disorder candidateN/A
2023-04-11 01:47 ESTNewsOmeros awarded $6.69M grant from NIH for cocaine use disorder treatmentN/A
2023-03-27 18:48 ESTNewsOmeros Q4: Strong Financials And IgAN Pipeline Readout In Q3 23N/A
2023-03-15 00:03 ESTNewsOmeros stock climbs amid Q4 Omidria royalty revenue; eyes FDA refiling for narsoplimabN/A
2023-03-14 08:12 ESTNewsOmeros Corporation (OMER) Q4 2022 Earnings Call TranscriptN/A
2023-03-13 17:09 ESTNewsOmeros GAAP EPS of -$0.73 misses by $0.16N/A
2023-03-13 02:04 ESTNewsOmeros Q4 2022 Earnings PreviewN/A
2023-02-08 10:56 ESTNewsOmeros: $200M Added To The Company's Balance Sheet, Upgrading To Strong BuyN/A
2023-02-06 20:54 ESTNewsOmeros up 35% in premarket trading following $200M milestone paymentN/A
2023-02-04 12:40 ESTNewsOmeros: Worst Has Been Priced In, We Like Its IgAN Pipeline, Initiating With A BuyN/A
2022-12-27 10:19 ESTNewsOmeros' Deafening SilenceN/A
2022-11-10 03:58 ESTNewsOmeros GAAP EPS of -$0.28 beats by $0.28N/A
2022-11-10 03:58 ESTNewsOmeros Corporation (OMER) Q3 2022 Earnings Call TranscriptN/A
2022-11-09 10:03 ESTNewsOmeros Q3 2022 Earnings PreviewN/A
2022-11-08 16:56 ESTNewsOmeros appeal of FDA Complete Response Letter on narsoplimab denied; shares down 7%N/A
2022-11-08 16:55 ESTNewsOmeros downgraded at Bank of America after FDA snub for narsoplimab appealN/A
2022-11-01 13:32 ESTNewsOmeros: FDA Appeal On Narsoplimab And Several 2023 Catalysts On DeckN/A
2022-10-05 09:58 ESTNewsOmeros: Taking It To The MaxN/A
2022-09-15 20:07 ESTNewsOmeros falls 11% after reporting clinical data for COVID-19 therapyN/A
2022-08-20 05:51 ESTNewsOmeros: Off To Never-Never LandN/A
2022-08-17 22:29 ESTNewsOmeros receives response from FDA on formal dispute resolution requestN/A
2022-08-16 11:56 ESTNewsOmeros: Managing An Investment After A Winning TradeN/A
2022-08-10 03:57 ESTNewsOmeros GAAP EPS of -$0.49N/A
2022-08-10 03:57 ESTNewsOmeros Corporation (OMER) CEO Gregory Demopulos on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-09 06:07 ESTNewsOmeros Q2 2022 Earnings PreviewN/A
2022-07-29 02:53 ESTNewsOmeros granted FDA’s orphan drug designation for PNH candidateN/A
2022-07-05 17:38 ESTNewsAfter gaining 69% in single trading day, Omeros stock gives back some gainsN/A
2022-07-04 07:08 ESTNewsOmeros: Follow The Bouncing BallN/A
2022-06-08 22:55 ESTNewsOmeros slips to 52-week low as stock down 9%N/A
2022-06-07 00:28 ESTNewsClover Health, Aurinia Pharma among the top 10 health care additions to Russell 3000 Index, Asensus Surgical, Clovis Oncology among top deletionsN/A
2022-06-02 12:43 ESTNewsOmeros: On Death's DoorN/A
2022-05-12 03:01 ESTNewsOmeros stock rises 7% after beating Q1 earnings estimateN/A
2022-05-11 07:21 ESTNewsOmeros GAAP EPS of -$0.53 beats by $0.08N/A
2022-05-11 07:21 ESTNewsOmeros Corporation (OMER) CEO Greg Demopulos on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-10 11:19 ESTNewsOmeros Q1 2022 Earnings PreviewN/A
2022-05-03 00:21 ESTNewsOmeros: The Weight Of The Wait, A ConundrumN/A
2022-03-02 04:45 ESTNewsOmeros Non-GAAP EPS of -$0.37 misses by $0.31N/A
2022-03-02 04:44 ESTNewsOmeros Corporation's (OMER) CEO Greg Demopulos On Q4 2021 Results - Earnings Call TranscriptN/A
2022-03-01 10:49 ESTNewsOmeros Q4 2021 Earnings PreviewN/A
2022-02-21 13:04 ESTNewsOmeros: Despite Its Promise, The CRL Is A Huge ObstacleN/A
2022-01-20 07:52 ESTNewsOmeros responds to Complete Response Letter on narsoplimab for kidney damageN/A
2022-01-19 00:54 ESTNewsOmeros could trade as a pure-play biotech after divesting Omidria - CantorN/A
2021-12-06 20:03 ESTNewsOmeros: A New Year BeckonsN/A
2021-12-02 22:53 ESTNewsOmeros to sell OMIDRIA franchise to Rayner Surgical for more than $1BN/A
2021-11-10 13:19 ESTNewsOmeros EPS beats by $0.01, beats on revenueN/A
2021-11-10 13:19 ESTNewsOmeros Corporation (OMER) CEO Greg Demopulos on Q3 2021 Results - Earnings Call TranscriptN/A

About Omeros Corporation (OMER):

Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, disorders of the central nervous system (CNS), and immune-related diseases. It provides OMIDRIA for use in cataract surgery or intraocular lens replacement in the United States. The company's clinical programs include Narsoplimab (OMS721/MASP-2) for hematopoietic stem-cell transplant-associated thrombotic microangiopathy (HSCT-TMA); that is in Phase III clinical trial for immunoglobulin A nephropathy (IgAN), atypical hemolytic uremic syndrome (aHUS), and COVID-19; and Phase II clinical trial to treat lupus nephritis and other renal diseases. Its clinical programs also consist of PPAR? (OMS405) to treat opioid and nicotine addiction; PDE7 (OMS527) for treating addiction and compulsive disorders, and movement disorders; and MASP-3 (OMS906) for paroxysmal nocturnal hemoglobinuria (PNH) and other alternative pathway disorders. The company's preclinical programs comprise MASP-2-small-molecule inhibitors used for the treatment of aHUS, IgAN, HSCT-TMA, and age-related macular degeneration; longer-acting second generation antibody targeting MASP-2; and MASP-3-small-molecule inhibitors to treat PNH and other alternative pathway disorders. Its preclinical programs include G protein-coupled receptor (GPCR) platform, including GPR174, GPR151, GPR161, and other Class A orphan GPCRs for treating immunologic, immuno-oncologic, metabolic, CNS, cardiovascular, musculoskeletal, and other disorders. The company was incorporated in 1994 and is headquartered in Seattle, Washington.

OMER Quotes by TradingView

See Advanced Chart

General

  • Name Omeros Corporation
  • Symbol OMER
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 277
  • Last Split Factor1:1
  • Last Split Date2009-10-02
  • Fiscal Year EndDecember
  • IPO Date2009-10-08
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryPharmaceuticals
  • Gic SubIndustryPharmaceuticals
  • Web URLhttp://www.omeros.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 15.4
  • Enterprise Value Revenue 18.49
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$1.77
  • Next Year EPS Estimate -$1.12
  • Next Quarter EPS Estimate -$0.54
  • Profit Margin -187%
  • Operating Margin -150%
  • Return on Assets -43%
  • Revenue 73.81 million
  • Earnings Per Share -$2.08
  • Revenue Per Share $1.29
  • Gross Profit 6.17 million
  • Quarterly Earnings Growth -68.2%
View More

Highlights

  • Market Capitalization 1.23 billion
  • EBITDA -81135000
  • PE Ratio -1.97
  • PEG Ratio -0.17
  • Analyst Target Price $27.33
  • Book Value Per Share -$2.65
View More

Share Statistics

  • Shares Outstanding 61.93 million
  • Shares Float 55.03 million
  • % Held by Insiders 441%
  • % Held by Institutions 57.36%
  • Shares Short 12.55 million
  • Shares Short Prior Month 12.76 million
  • Short Ratio 16
  • Short % of Float 21%
  • Short % of Shares Outstanding 20%
View More

Technicals

  • Beta 1.42
  • 52 Week High $23.14
  • 52 Week Low $9.25
  • 50 Day Moving Average 20.56
  • 200 Day Moving Average 14.72
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Omeros Corporation (OMER) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Omeros Corporation (OMER) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-01$N/A-$0.60-$0.6710.39%
2020-09-302020-11-09$N/A-$0.34-$0.4930.04%
2020-06-302020-08-10$N/A-$0.61-$0.59-4.1%
2020-03-312020-05-11$23.54 million-$0.53-$0.34-55.88%
2019-12-312020-03-02$33.42 million-$0.58-$0.40-45%
2019-09-302019-11-12$29.86 million-$0.33-$0.4119.02%
2019-06-302019-08-08$26.75 million-$0.29-$0.4434.09%
2019-03-312019-05-09$21.78 million-$0.50-$0.47-5.82%
2018-12-312019-03-01$22.02 million-$0.48-$0.7333.89%
2018-09-302018-11-08$4.61 million-$0.81-$0.71-14.62%
2018-06-302018-08-09$1.66 million-$0.70-$0.62-12.45%
2018-03-312018-05-10$1.59 million-$0.62-$0.59-5.68%
2017-12-312018-03-01$13.76 million-$0.34-$0.18-91.55%
2017-09-302017-11-09$21.66 million-$0.16-$0.3453.22%
2017-06-302017-08-08$17.15 million-$0.33-$0.3710.81%
2017-03-312017-05-10$12.26 million-$0.34-$0.364.23%
2016-12-312017-03-16$12.91 million-$0.33-$0.5641.96%
2016-09-302016-11-09$11.29 million-$0.34-$0.364.9%
2016-06-302016-08-09$10 million-$0.32-$0.4934.16%
2016-03-312016-05-10$7.42 million-$0.54-$0.43-25.58%
2015-12-312016-03-07$6.68 million-$0.49-$0.5917.87%
2015-09-302015-11-09$3.26 million-$0.53-$0.47-12.77%
2015-06-302015-08-10$3.19 million-$0.44-$0.5621.43%
2015-03-312015-05-11$388000-$0.51-$0.6319.05%
2014-12-312015-03-16$180000-$0.61-$0.621.61%
2014-09-302014-11-10$214000-$0.54-$0.598.47%
2014-06-302014-08-11$45000-$0.53-$0.565.36%
2014-03-312014-05-12$100000-$0.54-$0.45-20%
2013-12-312014-03-13$169000-$0.47-$0.38-23.68%
2013-09-302013-11-07$196000-$0.46-$0.44-4.55%
2013-06-302013-08-09$140000-$0.48-$0.38-26.32%
2013-03-312013-05-10$1.1 million-$0.40-$0.39-2.56%
2012-12-312013-03-18$1.58 million-$0.45-$0.34-32.35%
2012-09-302012-11-09$1.42 million-$0.36-$0.34-5.88%
2012-06-302012-08-07$1.53 million-$0.38-$0.36-5.56%
2012-03-312012-05-10$1.5 million-$0.35-$0.362.78%
2011-12-312012-03-15$1.14 million-$0.46-$0.35-31.43%
2011-09-302011-11-08$987000-$0.29-$0.3823.68%
2011-06-302011-08-09$1.16 million-$0.24-$0.3836.84%
2011-03-312011-05-10$1.24 million-$0.30-$0.3923.08%
2010-12-312011-03-15$976000-$0.32-$0.4934.69%
2010-09-302010-11-04$254000-$0.35-$0.3910.26%
2010-06-302010-08-10$497000-$0.36-$0.33-9.09%
2010-03-312010-05-12$378000-$0.31-$0.30-3.33%
2009-12-312010-03-31$434000-$0.28-$0.27-3.7%
2009-09-302009-11-19$442000-$0.33-$0.3710.81%

Omeros Corporation (OMER) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Omeros Corporation (OMER) Chart:

Omeros Corporation (OMER) News:

Below you will find a list of latest news for Omeros Corporation (OMER) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Omeros Corporation (OMER) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-04-1710CALL0 01009.1TRUE00
2025-04-1720CALL0 0514.25TRUE00
2025-04-1730CALL0 0376.61TRUE00
2025-04-1740CALL0 0168.52TRUE00
2025-04-1750CALL0 0155.85TRUE00
2025-04-1760CALL0 0134.96TRUE00
2025-04-1771.96CALL0 1127.69TRUE00
2025-04-1781.15CALL4 129118.55TRUE1.150
2025-04-1790.7CALL50 80117.85FALSE-0.13-0.16
2025-04-17100.4CALL415 465116.58FALSE0.010.03
2025-04-17110.3CALL22 448130.11FALSE0.30
2025-04-17120.18CALL1 140130.44FALSE0.180
2025-04-17130.15CALL0 289135.9FALSE00
2025-04-17140CALL0 0125.32FALSE00
2025-04-17150CALL0 0198.53FALSE00
2025-04-17160CALL0 0213.03FALSE00
2025-04-17170CALL0 0192.26FALSE00
2025-04-1710PUT0 0811.6FALSE00
2025-04-1720PUT0 0530.5FALSE00
2025-04-1730PUT0 0389.59FALSE00
2025-04-1740PUT0 0265.22FALSE00
2025-04-1750PUT0 0223.01FALSE00
2025-04-1760.1PUT65 399121.85FALSE-0.01-0.09
2025-04-1770.28PUT1 45116.76FALSE0.280
2025-04-1780.5PUT45 524113.31FALSE00
2025-04-1791.13PUT6 190107.21TRUE0.080.08
2025-04-17100PUT0 0115.01TRUE00
2025-04-17110PUT0 0128.42TRUE00
2025-04-17120PUT0 0142.9TRUE00
2025-04-17130PUT0 0140.04TRUE00
2025-04-17140PUT0 0181.13TRUE00
2025-04-17150PUT0 0185.44TRUE00
2025-04-17160PUT0 0185.82TRUE00
2025-04-17170PUT0 0154.5TRUE00
2025-05-1610CALL0 0633.86TRUE00
2025-05-1620CALL0 0191.99TRUE00
2025-05-1635.78CALL0 430174.19TRUE00
2025-05-1643.6CALL0 604162.6TRUE00
2025-05-1654.6CALL0 8092.48TRUE00
2025-05-1663.37CALL0 114110.46TRUE00
2025-05-1672.45CALL0 246103.01TRUE00
2025-05-1681.3CALL0 1155105.92TRUE00
2025-05-1691.25CALL0 7865.02FALSE00
2025-05-16100.05CALL2 1191105.14FALSE-0.85-0.94
2025-05-16110.57CALL3 847107.37FALSE0.570
2025-05-16120.4CALL0 769107.05FALSE00
2025-05-16130.4CALL0 61792.91FALSE00
2025-05-16140.2CALL10 225107.37FALSE0.20
2025-05-16150.1CALL0 156499.41FALSE00
2025-05-16160.42CALL0 411107.57FALSE00
2025-05-16170.09CALL0 89148.95FALSE00
2025-05-16180.09CALL0 59115.49FALSE00
2025-05-16190.35CALL0 7156.74FALSE00
2025-05-16200.05CALL0 633163.4FALSE00
2025-05-16250.23CALL0 17191.19FALSE00
2025-05-1610PUT0 0511.53FALSE00
2025-05-1620.3PUT0 2500334.49FALSE00
2025-05-1630.3PUT0 10245.78FALSE00
2025-05-1640PUT0 0208.47FALSE00
2025-05-1650.31PUT0 113107.85FALSE00
2025-05-1660.4PUT0 9295.65FALSE00
2025-05-1670.5PUT0 57111.69FALSE00
2025-05-1681.06PUT0 35867.89FALSE00
2025-05-1691.35PUT0 535107.23TRUE00
2025-05-16102.2PUT1 663100.47TRUE2.20
2025-05-16112.58PUT0 13695.84TRUE00
2025-05-16123.8PUT0 87104.22TRUE00
2025-05-16134.3PUT0 199.44TRUE00
2025-05-16144.5PUT0 180.75TRUE00
2025-05-16150PUT0 0103.39TRUE00
2025-05-16160PUT0 0157.01TRUE00
2025-05-16170PUT0 0105.34TRUE00
2025-05-16180PUT0 0112.43TRUE00
2025-05-16190PUT0 0182.84TRUE00
2025-05-16200PUT0 0190.3TRUE00
2025-05-16250PUT0 0152.21TRUE00
2025-08-1510CALL0 0437.53TRUE00
2025-08-1520CALL0 0184.66TRUE00
2025-08-1535.85CALL0 9142.37TRUE00
2025-08-1545.26CALL0 389.07TRUE00
2025-08-1554.4CALL0 3499.59TRUE00
2025-08-1563.9CALL0 1690.74TRUE00
2025-08-1573.11CALL0 196.88TRUE00
2025-08-1582.75CALL0 64896.39TRUE00
2025-08-1592.25CALL0 18698.14FALSE00
2025-08-15101.75CALL0 19764.02FALSE00
2025-08-15111.55CALL0 24597.01FALSE00
2025-08-15121.3CALL0 116091.46FALSE00
2025-08-15131.1CALL0 1077.38FALSE00
2025-08-15141.1CALL0 3998.85FALSE00
2025-08-15150.76CALL0 1037100.07FALSE00
2025-08-15160.67CALL0 1695.53FALSE00
2025-08-15200.71CALL0 24990.36FALSE00
2025-08-15250.75CALL0 7493.14FALSE00
2025-08-1510PUT0 0333.39FALSE00
2025-08-1520.05PUT0 1226.55FALSE00
2025-08-1530.23PUT0 10145.64FALSE00
2025-08-1540.43PUT0 10103.38FALSE00
2025-08-1550.43PUT0 50106.67FALSE00
2025-08-1560.7PUT0 4378.65FALSE00
2025-08-1571.08PUT0 168104.37FALSE00
2025-08-1581.8PUT0 1036103.73FALSE00
2025-08-1592.25PUT0 449103.13TRUE00
2025-08-15102.9PUT0 426104.28TRUE00
2025-08-15113.57PUT0 15101.61TRUE00
2025-08-15124.69PUT0 12102.79TRUE00
2025-08-15134.9PUT0 10102.12TRUE00
2025-08-15145.3PUT0 7107.78TRUE00
2025-08-15156PUT0 398.23TRUE00
2025-08-15166.6PUT0 29104.73TRUE00
2025-08-15200PUT0 092.92TRUE00
2025-08-15250PUT0 0102.83TRUE00
2025-11-2110CALL0 0373.87TRUE00
2025-11-2120CALL0 0231.83TRUE00
2025-11-2130CALL0 0105.28TRUE00
2025-11-2140CALL0 093.23TRUE00
2025-11-2150CALL0 0101.57TRUE00
2025-11-2160CALL0 098.67TRUE00
2025-11-2170CALL0 097.53TRUE00
2025-11-2180CALL0 087.55TRUE00
2025-11-2190CALL0 089.1FALSE00
2025-11-21100CALL0 092.17FALSE00
2025-11-21110CALL0 091.6FALSE00
2025-11-21120CALL0 071.93FALSE00
2025-11-21131.5CALL0 190.18FALSE00
2025-11-21140CALL0 072.76FALSE00
2025-11-21150CALL0 081.14FALSE00
2025-11-21160CALL0 079.38FALSE00
2025-11-21170CALL0 085.88FALSE00
2025-11-2110PUT0 0264.78FALSE00
2025-11-2120PUT0 0170.46FALSE00
2025-11-2130PUT0 0125.46FALSE00
2025-11-2140PUT0 0109.53FALSE00
2025-11-2150PUT0 089.81FALSE00
2025-11-2160PUT0 082.52FALSE00
2025-11-2170PUT0 0100.78FALSE00
2025-11-2180PUT0 0106.93FALSE00
2025-11-2190PUT0 0102.16TRUE00
2025-11-21100PUT0 099.8TRUE00
2025-11-21110PUT0 095.07TRUE00
2025-11-21120PUT0 098.26TRUE00
2025-11-21130PUT0 0102.19TRUE00
2025-11-21140PUT0 093.77TRUE00
2025-11-21150PUT0 091.83TRUE00
2025-11-21160PUT0 095.2TRUE00
2025-11-21170PUT0 091.33TRUE00
2025-12-1910CALL0 0333.59TRUE00
2025-12-1920CALL0 0188.38TRUE00
2025-12-1930CALL0 090.71TRUE00
2025-12-1940CALL0 0100.72TRUE00
2025-12-1950CALL0 098.58TRUE00
2025-12-1960CALL0 097.87TRUE00
2025-12-1970CALL0 088.53TRUE00
2025-12-1980CALL0 086.29TRUE00
2025-12-1992.8CALL0 589.41FALSE00
2025-12-19102.55CALL0 45891.27FALSE00
2025-12-19112.46CALL0 290.68FALSE00
2025-12-19121.93CALL0 30387.11FALSE00
2025-12-19151.3CALL0 876.51FALSE00
2025-12-19171.05CALL0 41791.07FALSE00
2025-12-1910PUT0 0250.84FALSE00
2025-12-1920PUT0 0161.52FALSE00
2025-12-1930PUT0 0124.67FALSE00
2025-12-1940PUT0 0101.81FALSE00
2025-12-1950.9PUT0 20101.07FALSE00
2025-12-1960PUT0 0103.69FALSE00
2025-12-1971.75PUT0 125104.49FALSE00
2025-12-1980PUT0 0100.64FALSE00
2025-12-1992.75PUT0 7999.97TRUE00
2025-12-19100PUT0 098.57TRUE00
2025-12-19110PUT0 097.59TRUE00
2025-12-19120PUT0 098.91TRUE00
2025-12-19150PUT0 097.15TRUE00
2025-12-191710.1PUT0 291.67TRUE00
2026-12-1810CALL0 00TRUE00
2026-12-1820CALL0 0112.67TRUE00
2026-12-1830CALL0 078.03TRUE00
2026-12-1840CALL0 089.44TRUE00
2026-12-1850CALL0 086.2TRUE00
2026-12-1870CALL0 094.47TRUE00
2026-12-18100CALL0 080.59FALSE00
2026-12-18122.78CALL0 2082.27FALSE00
2026-12-18152.74CALL0 3361.59FALSE00
2026-12-18171.9CALL1 279.58FALSE1.90
2026-12-1810PUT0 00FALSE00
2026-12-1820PUT0 00FALSE00
2026-12-1831.2PUT0 8220.23FALSE00
2026-12-1841.8PUT0 1167.36FALSE00
2026-12-1850PUT0 079.53FALSE00
2026-12-1870PUT0 088.64FALSE00
2026-12-18100PUT0 088.87TRUE00
2026-12-18127.1PUT0 186TRUE00
2026-12-18159.7PUT0 293.12TRUE00
2026-12-18170PUT0 088.92TRUE00
2027-01-1510CALL0 00TRUE00
2027-01-1520CALL0 0109.86TRUE00
2027-01-1530CALL0 083.48TRUE00
2027-01-1545.4CALL0 187.19TRUE00
2027-01-1556CALL0 1667.87TRUE00
2027-01-1574.4CALL3 10188.34TRUE4.40
2027-01-15103.5CALL0 379.88FALSE00
2027-01-15122.5CALL0 380.33FALSE00
2027-01-15152.3CALL1 19680.62FALSE-0.2-0.08
2027-01-15171.8CALL6 2575.51FALSE-0.4-0.18
2027-01-1510PUT0 00FALSE00
2027-01-1520PUT0 0202.07FALSE00
2027-01-1530PUT0 0195.22FALSE00
2027-01-1541.65PUT0 1124.19FALSE00
2027-01-1552PUT0 2078.05FALSE00
2027-01-1573.16PUT0 1092.36FALSE00
2027-01-15105.5PUT0 1289.21TRUE00
2027-01-15127.1PUT0 288.08TRUE00
2027-01-15159.5PUT0 188.18TRUE00
2027-01-15170PUT0 0102.45TRUE00

Latest OMER Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST100$2.015
Jun 13, 2022 7:59 PM EST100$2.015
Jun 13, 2022 7:59 PM EST388$2.015
Jun 13, 2022 7:59 PM EST112$2.015
Jun 13, 2022 7:59 PM EST42$2.015

Omeros Corporation (OMER) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000155837020007464/0001558370-20-007464-index.htm
2019-12-30UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1285819/000000000019016861/0000000000-19-016861-index.htm
2020-01-31UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1285819/000000000020000924/0000000000-20-000924-index.htm
2018-01-29SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1285819/000021545718003528/0000215457-18-003528-index.htm
2019-02-06SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1285819/000021545719004932/0000215457-19-004932-index.htm
2020-02-05SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1285819/000083423720005992/0000834237-20-005992-index.htm
2017-12-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924317029690/0000899243-17-029690-index.htm
2018-01-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924318000628/0000899243-18-000628-index.htm
2018-01-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924318000629/0000899243-18-000629-index.htm
2018-04-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924318009872/0000899243-18-009872-index.htm
2018-04-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924318009873/0000899243-18-009873-index.htm
2018-04-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924318010008/0000899243-18-010008-index.htm
2018-05-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924318013086/0000899243-18-013086-index.htm
2018-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924318017006/0000899243-18-017006-index.htm
2018-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924318017007/0000899243-18-017007-index.htm
2018-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924318017008/0000899243-18-017008-index.htm
2018-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924318017010/0000899243-18-017010-index.htm
2018-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924318017011/0000899243-18-017011-index.htm
2018-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924318017013/0000899243-18-017013-index.htm
2018-07-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924318019862/0000899243-18-019862-index.htm
2018-07-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924318020780/0000899243-18-020780-index.htm
2018-08-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924318023667/0000899243-18-023667-index.htm
2019-02-123Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924319003362/0000899243-19-003362-index.htm
2019-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924319003363/0000899243-19-003363-index.htm
2019-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924319003364/0000899243-19-003364-index.htm
2019-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924319003365/0000899243-19-003365-index.htm
2019-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924319003367/0000899243-19-003367-index.htm
2019-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924319016488/0000899243-19-016488-index.htm
2019-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924319016489/0000899243-19-016489-index.htm
2019-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924319016490/0000899243-19-016490-index.htm
2019-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924319016492/0000899243-19-016492-index.htm
2019-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924319016495/0000899243-19-016495-index.htm
2019-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924319016497/0000899243-19-016497-index.htm
2019-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924319016501/0000899243-19-016501-index.htm
2019-06-113Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924319016504/0000899243-19-016504-index.htm
2019-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924319016506/0000899243-19-016506-index.htm
2019-10-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924319025638/0000899243-19-025638-index.htm
2019-12-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924319028629/0000899243-19-028629-index.htm
2019-12-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924319029501/0000899243-19-029501-index.htm
2019-12-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924319029502/0000899243-19-029502-index.htm
2020-02-123Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924320004399/0000899243-20-004399-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000089924320004400/0000899243-20-004400-index.htm
2017-11-07SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1285819/000092963817000842/0000929638-17-000842-index.htm
2018-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1285819/000092963818000300/0000929638-18-000300-index.htm
2020-05-04SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1285819/000092963820000579/0000929638-20-000579-index.htm
2018-02-09SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1285819/000104188518000012/0001041885-18-000012-index.htm
2019-01-30SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1285819/000104188519000016/0001041885-19-000016-index.htm
2020-02-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1285819/000104188520000011/0001041885-20-000011-index.htm
2019-12-04S-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuershttps://www.sec.gov/Archives/edgar/data/1285819/000104746919006632/0001047469-19-006632-index.htm
2019-12-04424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1285819/000104746919006643/0001047469-19-006643-index.htm
2019-12-06424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1285819/000104746919006722/0001047469-19-006722-index.htm
2020-08-10424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1285819/000104746920004475/0001047469-20-004475-index.htm
2020-08-10424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1285819/000104746920004476/0001047469-20-004476-index.htm
2020-08-13424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1285819/000104746920004572/0001047469-20-004572-index.htm
2020-08-13424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1285819/000104746920004574/0001047469-20-004574-index.htm
2020-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1285819/000108514620000787/0001085146-20-000787-index.htm
2019-12-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000110465919070697/0001104659-19-070697-index.htm
2020-01-10CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1285819/000110465920002951/0001104659-20-002951-index.htm
2020-01-13AWAmendment Withdrawal Requesthttps://www.sec.gov/Archives/edgar/data/1285819/000110465920003470/0001104659-20-003470-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1285819/000110465920021736/0001104659-20-021736-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1285819/000110465920021842/0001104659-20-021842-index.htm
2020-08-10FWPFiling under Securities Act Rules 163/433 of free writing prospectuseshttps://www.sec.gov/Archives/edgar/data/1285819/000110465920092744/0001104659-20-092744-index.htm
2020-08-10305B2Filing [Trust Indenture Act]https://www.sec.gov/Archives/edgar/data/1285819/000110465920092747/0001104659-20-092747-index.htm
2020-08-12FWPFiling under Securities Act Rules 163/433 of free writing prospectuseshttps://www.sec.gov/Archives/edgar/data/1285819/000110465920093476/0001104659-20-093476-index.htm
2020-08-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000110465920095326/0001104659-20-095326-index.htm
2019-03-08SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1285819/000114420419012997/0001144204-19-012997-index.htm
2019-05-10SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1285819/000114420419025259/0001144204-19-025259-index.htm
2017-08-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000119312517265505/0001193125-17-265505-index.htm
2017-10-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000119312517304636/0001193125-17-304636-index.htm
2017-10-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000119312517311379/0001193125-17-311379-index.htm
2018-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1285819/000119312518045759/0001193125-18-045759-index.htm
2018-03-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000119312518096839/0001193125-18-096839-index.htm
2018-04-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000119312518116023/0001193125-18-116023-index.htm
2018-05-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000119312518169610/0001193125-18-169610-index.htm
2018-05-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000119312518172720/0001193125-18-172720-index.htm
2018-06-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000119312518195704/0001193125-18-195704-index.htm
2018-10-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000119312518294184/0001193125-18-294184-index.htm
2018-11-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000119312518322542/0001193125-18-322542-index.htm
2018-11-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000119312518327708/0001193125-18-327708-index.htm
2019-01-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000119312519009075/0001193125-19-009075-index.htm
2019-02-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000119312519036058/0001193125-19-036058-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1285819/000119312519038252/0001193125-19-038252-index.htm
2019-03-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000119312519059222/0001193125-19-059222-index.htm
2019-03-01POSASRPost-effective Amendment to an automatic shelf registration statementhttps://www.sec.gov/Archives/edgar/data/1285819/000119312519059276/0001193125-19-059276-index.htm
2019-03-01POS AMPost-Effective amendments for registration statementhttps://www.sec.gov/Archives/edgar/data/1285819/000119312519059320/0001193125-19-059320-index.htm
2019-06-11S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1285819/000119312519170318/0001193125-19-170318-index.htm
2018-03-0110-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1285819/000128581918000003/0001285819-18-000003-index.htm
2018-05-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1285819/000128581918000006/0001285819-18-000006-index.htm
2018-08-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1285819/000128581918000011/0001285819-18-000011-index.htm
2018-11-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1285819/000128581918000014/0001285819-18-000014-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000141588920000610/0001415889-20-000610-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000141588920000611/0001415889-20-000611-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000141588920000612/0001415889-20-000612-index.htm
2020-03-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000141588920000797/0001415889-20-000797-index.htm
2020-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000141588920001228/0001415889-20-001228-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000141588920001531/0001415889-20-001531-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000141588920001532/0001415889-20-001532-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000141588920001533/0001415889-20-001533-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000141588920001534/0001415889-20-001534-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000141588920001535/0001415889-20-001535-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000141588920001536/0001415889-20-001536-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000141588920001537/0001415889-20-001537-index.htm
2020-10-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1285819/000141588920002497/0001415889-20-002497-index.htm
2019-07-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000155837019006625/0001558370-19-006625-index.htm
2019-08-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000155837019007697/0001558370-19-007697-index.htm
2019-08-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000155837019007698/0001558370-19-007698-index.htm
2019-08-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1285819/000155837019007702/0001558370-19-007702-index.htm
2019-11-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000155837019010800/0001558370-19-010800-index.htm
2019-11-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1285819/000155837019010806/0001558370-19-010806-index.htm
2020-02-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000155837020000682/0001558370-20-000682-index.htm
2020-03-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000155837020001887/0001558370-20-001887-index.htm
2020-03-0210-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1285819/000155837020001891/0001558370-20-001891-index.htm
2020-04-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1285819/000155837020004646/0001558370-20-004646-index.htm
2020-04-29DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1285819/000155837020004658/0001558370-20-004658-index.htm
2020-05-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000155837020006245/0001558370-20-006245-index.htm
2020-05-1110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1285819/000155837020006254/0001558370-20-006254-index.htm
2020-06-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000155837020007464/0001558370-20-007464-index.htm
2020-08-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000155837020010177/0001558370-20-010177-index.htm
2020-08-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1285819/000155837020010182/0001558370-20-010182-index.htm
2017-11-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000156459017023228/0001564590-17-023228-index.htm
2018-03-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000156459018004112/0001564590-18-004112-index.htm
2018-04-30DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1285819/000156459018009842/0001564590-18-009842-index.htm
2018-05-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000156459018012972/0001564590-18-012972-index.htm
2018-08-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000156459018021051/0001564590-18-021051-index.htm
2019-04-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1285819/000156459019013704/0001564590-19-013704-index.htm
2019-05-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000156459019017957/0001564590-19-017957-index.htm
2019-06-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1285819/000156459019022265/0001564590-19-022265-index.htm
2017-11-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1285819/000162828017011326/0001628280-17-011326-index.htm
2019-03-0110-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1285819/000162828019002324/0001628280-19-002324-index.htm
2019-05-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1285819/000162828019006430/0001628280-19-006430-index.htm
2018-10-04CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1285819/999999999718008375/9999999997-18-008375-index.htm
2019-04-04CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1285819/999999999719002349/9999999997-19-002349-index.htm
2019-09-11CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1285819/999999999719006776/9999999997-19-006776-index.htm
2020-08-06CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1285819/999999999720004327/9999999997-20-004327-index.htm

Omeros Corporation (OMER) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Omeros Corporation (OMER). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 441%
Institutional Ownership: 5736%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2018-05-15MICHAEL A JACOBSENVP Finance and CAOBuy5,000.009.3746,850.0013,500.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318013086/0000899243-18-013086-index.htm
2018-01-03Marcia S. KelbonVP Patent and General CounselSell62,528.0021.451,341,225.60176,641.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318000629/0000899243-18-000629-index.htm
2018-01-03Marcia S. KelbonVP Patent and General CounselBuy3,000.006.0518,150.00179,641.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318000629/0000899243-18-000629-index.htm
2018-01-03Marcia S. KelbonVP Patent and General CounselBuy5,004.006.0530,274.20184,645.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318000629/0000899243-18-000629-index.htm
2018-07-12Marcia S. KelbonVP Patent and General CounselSell4,277.0021.4891,886.21184,645.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318019862/0000899243-18-019862-index.htm
2018-07-26Marcia S. KelbonVP Patent and General CounselSell35,000.0021.53753,686.50184,645.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318020780/0000899243-18-020780-index.htm
2019-12-14Peter A MD DemopulosDirectorBuy3,334.007.5625,205.04188,516.00https://www.sec.gov/Archives/edgar/data/1285819/000089924319029501/0000899243-19-029501-index.htm
2018-07-12Marcia S. KelbonVP Patent and General CounselBuy4,277.004.1017,535.70188,922.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318019862/0000899243-18-019862-index.htm
2018-07-26Marcia S. KelbonVP Patent and General CounselBuy8,000.006.0548,400.00192,645.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318020780/0000899243-18-020780-index.htm
2018-07-27Marcia S. KelbonVP Patent and General CounselSell5,723.0021.73124,356.78192,645.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318020780/0000899243-18-020780-index.htm
2018-08-30Marcia S. KelbonVP Patent and General CounselSell35,000.0024.45855,750.00192,645.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318023667/0000899243-18-023667-index.htm
2018-08-31Marcia S. KelbonVP Patent and General CounselSell5,337.0025.93138,376.13192,645.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318023667/0000899243-18-023667-index.htm
2018-05-14MICHAEL A JACOBSENVP Finance and CAOBuy10,980.009.37102,882.6019,480.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318013086/0000899243-18-013086-index.htm
2018-08-31Marcia S. KelbonVP Patent and General CounselSell2,192.0025.3155,469.44197,982.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318023667/0000899243-18-023667-index.htm
2018-07-27Marcia S. KelbonVP Patent and General CounselBuy5,723.004.1023,464.30198,368.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318020780/0000899243-18-020780-index.htm
2017-12-28Gregory A MD DemopulosChairman, CEO & PresidentBuy102,040.002.45249,998.001,987,025.00https://www.sec.gov/Archives/edgar/data/1285819/000089924317029690/0000899243-17-029690-index.htm
2018-08-31Marcia S. KelbonVP Patent and General CounselBuy7,529.004.1030,868.90200,174.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318023667/0000899243-18-023667-index.htm
2018-08-31Marcia S. KelbonVP Patent and General CounselBuy8,000.006.0548,400.00200,645.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318023667/0000899243-18-023667-index.htm
2017-12-28Gregory A MD DemopulosChairman, CEO & PresidentBuy39,961.004.10163,840.102,026,986.00https://www.sec.gov/Archives/edgar/data/1285819/000089924317029690/0000899243-17-029690-index.htm
2019-06-07Marcia S. KelbonVP Patent and General CounselBuy10,000.006.0560,500.00210,645.00https://www.sec.gov/Archives/edgar/data/1285819/000089924319016488/0000899243-19-016488-index.htm
2018-05-15MICHAEL A JACOBSENVP Finance and CAOBuy12,812.009.37120,048.4421,312.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318013086/0000899243-18-013086-index.htm
2018-07-26Marcia S. KelbonVP Patent and General CounselBuy35,000.004.10143,500.00219,645.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318020780/0000899243-18-020780-index.htm
2018-08-30Marcia S. KelbonVP Patent and General CounselBuy35,000.004.10143,500.00227,645.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318023667/0000899243-18-023667-index.htm
2018-01-03Marcia S. KelbonVP Patent and General CounselBuy62,528.009.37585,887.36239,169.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318000629/0000899243-18-000629-index.htm
2019-10-14Thomas J. CableDirectorSell5,000.0015.1275,590.0035,067.00https://www.sec.gov/Archives/edgar/data/1285819/000089924319025638/0000899243-19-025638-index.htm
2019-12-03Thomas J. CableDirectorSell10,000.0014.41144,148.0035,067.00https://www.sec.gov/Archives/edgar/data/1285819/000089924319028629/0000899243-19-028629-index.htm
2020-05-13Thomas J. CableDirectorSell5,000.0014.4071,998.5035,067.00https://www.sec.gov/Archives/edgar/data/1285819/000141588920001228/0001415889-20-001228-index.htm
2020-05-13Thomas J. CableDirectorBuy5,000.005.9229,600.0040,067.00https://www.sec.gov/Archives/edgar/data/1285819/000141588920001228/0001415889-20-001228-index.htm
2019-12-03Thomas J. CableDirectorBuy10,000.007.5675,600.0045,067.00https://www.sec.gov/Archives/edgar/data/1285819/000089924319028629/0000899243-19-028629-index.htm
2019-12-14Leroy E. MD PhD HoodDirectorBuy10,000.007.5675,600.0064,390.00https://www.sec.gov/Archives/edgar/data/1285819/000089924319029502/0000899243-19-029502-index.htm
2020-03-13Leroy E. MD PhD HoodDirectorBuy5,000.005.9229,600.0069,390.00https://www.sec.gov/Archives/edgar/data/1285819/000141588920000797/0001415889-20-000797-index.htm
2018-01-03MICHAEL A JACOBSENVP Finance and CAOSell1,020.0022.4522,899.007,500.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318000628/0000899243-18-000628-index.htm
2018-01-04MICHAEL A JACOBSENVP Finance and CAOBuy1,000.009.379,370.008,500.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318000628/0000899243-18-000628-index.htm
2018-05-14MICHAEL A JACOBSENVP Finance and CAOSell10,980.0022.45246,501.008,500.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318013086/0000899243-18-013086-index.htm
2018-05-15MICHAEL A JACOBSENVP Finance and CAOSell12,812.0024.95319,659.408,500.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318013086/0000899243-18-013086-index.htm
2018-01-03MICHAEL A JACOBSENVP Finance and CAOBuy1,020.009.379,557.408,520.00https://www.sec.gov/Archives/edgar/data/1285819/000089924318000628/0000899243-18-000628-index.htm